Loading…
Greenwich LifeSciences, Inc. is projected to rise to $45.34 by 2027, a +55% move from its current price of $29.23. GLSI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $28.16 | $29.24 | $30.36 | +0.03% |
| May 30 | $27.74 | $29.25 | $30.84 | +0.06% |
| May 31 | $27.42 | $29.26 | $31.22 | +0.10% |
| Jun 1 | $27.15 | $29.27 | $31.55 | +0.13% |
| Jun 2 | $26.92 | $29.28 | $31.84 | +0.16% |
| Jun 3 | $26.72 | $29.29 | $32.10 | +0.19% |
| Jun 4 | $26.53 | $29.30 | $32.35 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.53 | $29.30 | $32.35 | +0.22% |
| Week 2 | $25.52 | $29.36 | $33.78 | +0.45% |
| Week 3 | $24.78 | $29.43 | $34.94 | +0.67% |
| Week 4 | $24.18 | $29.49 | $35.96 | +0.89% |
| Week 5 | $23.68 | $29.56 | $36.90 | +1.12% |
| Week 6 | $23.23 | $29.62 | $37.77 | +1.34% |
| Week 7 | $22.84 | $29.69 | $38.60 | +1.57% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company focused on cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product GP2 is in Phase III clinical trials to prevent breast cancer recurrences in patients who have previously undergone surgery.
Its FLAMINGO-01 program is in Phase III and designed to evaluate GLSI-100 (GP2 + GM-CSF) in HER2-positive breast cancer patients. Greenwich LifeSciences was formerly Norwell, Inc., and changed its name to Greenwich LifeSciences, Inc. in March 2018.
The company was incorporated in 2006 and is headquartered in Stafford, Texas. It trades as GLSI in the Healthcare sector.
Greenwich LifeSciences, Inc. (GLSI) is a Healthcare stock. Its current price is $27.65 and its market capitalization is $383.08M.
It ranks 3271. The stock shows a bullish technical leaning with RSI14 at 60, and moving averages at SMA50 = $24.89 and SMA200 = $18.06. Support is at $21.60 and resistance at $27.74, with a 30-day range of $21.62 to $35.37 and an annualized volatility of 70%.
Forecast outlook features a multi-year path with 2026 avg $27.65 (min $19.47, max $40.82; ROI 0; sentiment NEUTRAL), followed by 2027 avg $41.42, 2028 avg $51.24, 2029 avg $50.22, 2030 avg $57.03, 2040 avg $145.51, and 2050 avg $242.59 (all with bullish sentiment and respective ROI figures in the data).
A major floor 34.8% below — a decisive break under it would weaken the trend.
The nearest floor, 26.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 17.4% above — clearing it would confirm fresh momentum.
Key GLSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GLSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.76 | Buy | $27.85 | Buy |
| MA 10 | $27.04 | Buy | $27.00 | Buy |
| MA 20 | $25.10 | Buy | $26.01 | Buy |
| MA 50 | $24.93 | Buy | $25.15 | Buy |
| MA 100 | $25.60 | Buy | $23.49 | Buy |
| MA 200 | $18.23 | Buy | $20.20 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.53 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 141.62 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.45 | Buy |
| ROC (12) | 27.87 | Buy |
| Bollinger %B (20,2) | 0.98 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 2.61 | Buy |
| Ultimate (7,14,28) | 71.69 | Sell |
| Momentum (10) | 4.52 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 28.22 | Buy |
| ADX (14) | 14.10 | Neutral |
| ATR (14) | 0.88 | Info |
Near-term technical picture is bullish. RSI14 sits at 60, and the price is above key moving averages, with SMA50 at $24.89 and SMA200 at $18.06.
Support is pegged at $21.60 and resistance at $27.74. The 30-day range spans from $21.62 to $35.37, reflecting price activity over the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.47 | $29.23 | $43.96 | 0% | Neutral | |
| $34.66 | $45.34 | $63.54 | +55% | Bullish | |
| $41.77 | $56.81 | $83.39 | +94% | Bullish | |
| $39.97 | $56.17 | $85.52 | +92% | Bullish | |
| $44.30 | $64.14 | $100.67 | +119% | Bullish | |
| $46.42 | $69.05 | $111.31 | +136% | Bullish | |
| $43.58 | $66.50 | $109.77 | +128% | Bullish | |
| $59.29 | $92.70 | $156.35 | +217% | Bullish | |
| $70.87 | $113.41 | $195.08 | +288% | Bullish | |
| $70.35 | $115.13 | $201.68 | +294% | Bullish | |
| $99.65 | $180.97 | $342.02 | +519% | Bullish | |
| $139.16 | $305.54 | $643.95 | +945% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.47 | $29.23 | $34.29 | +0.00% |
| June 2026 | $24.60 | $29.12 | $35.47 | -0.37% |
| July 2026 | $25.12 | $30.09 | $37.32 | +3.32% |
| August 2026 | $24.33 | $29.41 | $36.99 | -2.27% |
| September 2026 | $24.00 | $29.23 | $37.18 | -0.60% |
| October 2026 | $25.77 | $31.61 | $40.62 | +8.14% |
| November 2026 | $27.13 | $33.49 | $43.42 | +5.94% |
| December 2026 | $27.08 | $33.62 | $43.96 | +0.40% |
Click any year to see its month-by-month GLSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GLSI could reach as high as $43.96, with a base case around $29.23 and support toward $19.47 — roughly 0% from $29.23. Price action looks broadly range-bound.
Expect GLSI to range from $34.66 to $63.54 through 2027. The $45.34 average target implies a +55% move from current prices. That is up +55% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The GLSI price prediction for 2028 points to an average of $56.81 (low $41.77, high $83.39) — a potential gain of +94% on today's $29.23. Momentum favours further upside here.
In 2029, GLSI is projected to trade between $39.97 and $85.52, averaging $56.17 — a potential gain of +92% from today's $29.23. That is -1% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Greenwich LifeSciences, Inc.'s 2030 outlook centres on $64.14, within a $44.30 to $100.67 range. That is up +14% on the projected 2029 average. That marks a +119% change versus current levels. Momentum favours further upside here.
By 2031, GLSI could reach as high as $111.31, with a base case around $69.05 and support toward $46.42 — roughly +136% from $29.23. Buyers look set to stay in control over this stretch.
Expect GLSI to range from $43.58 to $109.77 through 2032. The $66.50 average target implies a +128% move from current prices. That is -4% versus the projected 2031 average. Momentum favours further upside here.
The GLSI price prediction for 2033 points to an average of $92.70 (low $59.29, high $156.35) — a potential gain of +217% on today's $29.23. Buyers look set to stay in control over this stretch.
In 2034, GLSI is projected to trade between $70.87 and $195.08, averaging $113.41 — a potential gain of +288% from today's $29.23. That is up +22% on the projected 2033 average. Momentum favours further upside here.
Greenwich LifeSciences, Inc.'s 2035 outlook centres on $115.13, within a $70.35 to $201.68 range. That is up +2% on the projected 2034 average. That marks a +294% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GLSI could reach as high as $342.02, with a base case around $180.97 and support toward $99.65 — roughly +519% from $29.23. Momentum favours further upside here.
Expect GLSI to range from $139.16 to $643.95 through 2050. The $305.54 average target implies a +945% move from current prices. That is up +69% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GLSI today (≈ 34.211427 GLSI) could be worth
$10,453.02
+$9,453.02 (+945%) by 2050 · US Dollar
Based on the average projected GLSI price of $305.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GLSIwould be worth at today's price.
$1,000 invested in GLSI on May 27, 2025 (≈ 100.200405 GLSI) would be worth
$2,928.86
+$1,928.86 (+192.9%) today · 2.93× · US Dollar
Based on a GLSI entry price of $9.98 vs. today's $29.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.32 | $1,069.91 | +7.0% |
| 1 month ago | $23.99 | $1,218.42 | +21.8% |
| 3 months ago | $28.12 | $1,039.47 | +3.9% |
| 6 months ago | $8.73 | $3,348.22 | +234.8% |
| 1 year ago | $9.98 | $2,928.86 | +192.9% |
| All time (5.0y) ago | $41.78 | $699.62 | -30.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GLSI forecast.
Our base-case forecast reaches $58.00 around 2030.
Implied market cap at $58.00: $803.56M
The multi-year forecast outlines a bullish trajectory with rising averages beyond 2026. The 2026 forecast shows an average of $27.65 with neutral sentiment and 0% ROI.
By 2030, the average forecast climbs to $57.03 with a 106.3% ROI and bullish sentiment. The path remains bullish into 2040, where the average is projected to $145.51 with a 426.2% ROI, and into 2050 with an average of $242.59 and a 777.4% ROI.
These figures are estimates and not guarantees. They illustrate potential price paths under the given forecast scenario and should be interpreted with awareness of uncertainty and market risk.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $57.03, with a min of $39.42 and a max of $89.46; ROI 106.3%; sentiment BULLISH.
Current price $27.65; Market cap $383.08M.
Avg $41.42; min $31.66; max $58.04; ROI 49.8; sentiment BULLISH.
Avg $145.51; min $80.27; max $274.65; ROI 426.2; sentiment BULLISH.
Low $21.62; High $35.37.
Greenwich LifeSciences, Inc. Community Discussion
0Share your Greenwich LifeSciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.